Vor bio to present at keystone symposia precision genome engineering meeting

Presentations showcase breadth of vor bio's multiplex editing capability including base editing of human hematopoietic stem and progenitor cells (hspcs) enabling new therapeutic approaches following transplant in patients with acute myeloid leukemia (aml) presentations showcase breadth of vor bio's multiplex editing capability including base editing of human hematopoietic stem and progenitor cells (hspcs) enabling new therapeutic approaches following transplant in patients with acute myeloid leukemia (aml)
VOR Ratings Summary
VOR Quant Ranking